HCW Biologics (HCWB) Competitors $4.23 -0.31 (-6.83%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$4.12 -0.11 (-2.48%) As of 06:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HCWB vs. IMA, JATT, MTVA, OKUR, ITRM, RENB, MAAQ, TENX, LEXX, and DAREShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include ImageneBio (IMA), JATT Acquisition (JATT), MetaVia (MTVA), OnKure Therapeutics (OKUR), Iterum Therapeutics (ITRM), Renovaro (RENB), Mana Capital Acquisition (MAAQ), Tenax Therapeutics (TENX), Lexaria Bioscience (LEXX), and Dare Bioscience (DARE). These companies are all part of the "pharmaceutical products" industry. HCW Biologics vs. Its Competitors ImageneBio JATT Acquisition MetaVia OnKure Therapeutics Iterum Therapeutics Renovaro Mana Capital Acquisition Tenax Therapeutics Lexaria Bioscience Dare Bioscience ImageneBio (NASDAQ:IMA) and HCW Biologics (NASDAQ:HCWB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk. Is IMA or HCWB more profitable? ImageneBio has a net margin of 0.00% compared to HCW Biologics' net margin of -1,368.55%. HCW Biologics' return on equity of 0.00% beat ImageneBio's return on equity.Company Net Margins Return on Equity Return on Assets ImageneBioN/A -23.94% -21.62% HCW Biologics -1,368.55%N/A -40.72% Which has more volatility and risk, IMA or HCWB? ImageneBio has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, HCW Biologics has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500. Do analysts rate IMA or HCWB? ImageneBio currently has a consensus price target of $35.50, suggesting a potential upside of 330.30%. HCW Biologics has a consensus price target of $35.00, suggesting a potential upside of 727.42%. Given HCW Biologics' stronger consensus rating and higher possible upside, analysts plainly believe HCW Biologics is more favorable than ImageneBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ImageneBio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50HCW Biologics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders hold more shares of IMA or HCWB? 75.0% of ImageneBio shares are held by institutional investors. Comparatively, 3.0% of HCW Biologics shares are held by institutional investors. 5.9% of ImageneBio shares are held by company insiders. Comparatively, 42.7% of HCW Biologics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable earnings & valuation, IMA or HCWB? HCW Biologics has lower revenue, but higher earnings than ImageneBio. ImageneBio is trading at a lower price-to-earnings ratio than HCW Biologics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImageneBio$9.16M3.61-$49.23M-$7.68-1.07HCW Biologics$2.57M3.54-$30.02M-$14.04-0.30 Does the media favor IMA or HCWB? In the previous week, HCW Biologics had 5 more articles in the media than ImageneBio. MarketBeat recorded 5 mentions for HCW Biologics and 0 mentions for ImageneBio. HCW Biologics' average media sentiment score of 0.42 beat ImageneBio's score of 0.00 indicating that HCW Biologics is being referred to more favorably in the news media. Company Overall Sentiment ImageneBio Neutral HCW Biologics Neutral SummaryHCW Biologics beats ImageneBio on 9 of the 15 factors compared between the two stocks. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCWB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.09M$3.15B$5.80B$10.45BDividend YieldN/A2.36%5.61%4.57%P/E Ratio-0.3021.0580.3526.85Price / Sales3.54444.59561.75178.85Price / CashN/A44.8326.0131.15Price / Book-0.709.6215.726.42Net Income-$30.02M-$53.02M$3.30B$271.73M7 Day Performance-13.67%1.43%3.96%2.82%1 Month Performance22.61%3.42%5.35%6.60%1 Year Performance-82.75%11.20%80.24%28.60% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.9652 of 5 stars$4.23-6.8%$35.00+727.4%-82.7%$9.09M$2.57M-0.3040IMAImageneBio2.5717 of 5 stars$8.52-4.9%$35.50+316.7%-59.8%$34.25M$9.16M-1.1170High Trading VolumeJATTJATT AcquisitionN/A$1.92-4.0%N/A-55.2%$33.12MN/A0.003High Trading VolumeMTVAMetaVia1.7657 of 5 stars$1.33-11.3%$7.50+463.9%N/A$32.19MN/A0.008High Trading VolumeOKUROnKure Therapeutics3.0078 of 5 stars$2.37-0.8%$32.33+1,264.3%N/A$32.07MN/A-0.49N/AITRMIterum Therapeutics2.5281 of 5 stars$0.68-0.7%$9.00+1,224.9%-36.5%$32.04MN/A-0.8010Gap UpRENBRenovaro0.4446 of 5 stars$0.18-4.0%N/A-66.3%$31.50MN/A-0.2420Upcoming EarningsGap UpMAAQMana Capital AcquisitionN/A$3.79-0.9%N/A+1,325.0%$30.79MN/A0.001Gap UpTENXTenax Therapeutics2.5085 of 5 stars$6.30+3.4%$18.00+185.7%+79.6%$28.73MN/A-6.859High Trading VolumeLEXXLexaria Bioscience3.2546 of 5 stars$1.46+12.3%$4.00+174.0%-62.0%$28.56M$615.92K-2.187Positive NewsDAREDare Bioscience2.093 of 5 stars$2.10+3.4%$10.00+376.2%-35.0%$28.31M$10K-0.9830 Related Companies and Tools Related Companies ImageneBio Competitors JATT Acquisition Competitors MetaVia Competitors OnKure Therapeutics Competitors Iterum Therapeutics Competitors Renovaro Competitors Mana Capital Acquisition Competitors Tenax Therapeutics Competitors Lexaria Bioscience Competitors Dare Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCWB) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThis Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top...Crypto 101 Media | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCWB Stock Alerts